Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C8H14O4S |
| Molecular Weight | 206.259 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)CCC(CCCS)C(O)=O
InChI
InChIKey=FNLNSQHJKVQCBP-UHFFFAOYSA-N
InChI=1S/C8H14O4S/c9-7(10)4-3-6(8(11)12)2-1-5-13/h6,13H,1-5H2,(H,9,10)(H,11,12)
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Enantiospecificity of glutamate carboxypeptidase II inhibition. | 2005 Apr 7 |
|
| The central nervous system effects, pharmacokinetics and safety of the NAALADase-inhibitor GPI 5693. | 2005 Aug |
|
| 2-MPPA, a selective glutamate carboxypeptidase II inhibitor, attenuates morphine tolerance but not dependence in C57/Bl mice. | 2005 Dec |
|
| Structural optimization of thiol-based inhibitors of glutamate carboxypeptidase II by modification of the P1' side chain. | 2006 May 18 |
|
| The preventive and therapeutic effects of GCPII (NAALADase) inhibition on painful and sensory diabetic neuropathy. | 2006 Sep 25 |
|
| Oral administration of the NAALADase inhibitor GPI-5693 attenuates cocaine-induced reinstatement of drug-seeking behavior in rats. | 2010 Feb 10 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
254737-29-6
Created by
admin on Sat Dec 16 11:48:14 GMT 2023 , Edited by admin on Sat Dec 16 11:48:14 GMT 2023
|
PRIMARY | |||
|
10198171
Created by
admin on Sat Dec 16 11:48:14 GMT 2023 , Edited by admin on Sat Dec 16 11:48:14 GMT 2023
|
PRIMARY | |||
|
TV8F3S5KLG
Created by
admin on Sat Dec 16 11:48:14 GMT 2023 , Edited by admin on Sat Dec 16 11:48:14 GMT 2023
|
PRIMARY | |||
|
GPI-5693
Created by
admin on Sat Dec 16 11:48:14 GMT 2023 , Edited by admin on Sat Dec 16 11:48:14 GMT 2023
|
PRIMARY | Selective glutamate carboxypeptidase II (GCP II) inhibitor (IC50 = 90 nM). Selective for GCP II over NMDA, kainate and AMPA glutamate receptors and MMP-1, -2, -3, -7, -9, ACE and NEP metalloproteases. Antinociceptive in a rat model of neuropathic pain and protects against motor neuron death in familial amyotrophic lateral sclerosis mice. Orally bioavailable. |
ACTIVE MOIETY
